Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment
6/4/2012 10:26:45 AM
More...
|
Telormedix and SUPSI Receive Funding from CTI/KTI for Research Collaboration on Molecular Modeling of Drug-Target Interactions
3/6/2012 10:01:39 AM
More...
|
Telormedix Elected Member of TIMER Collaborative Research Program
1/31/2012 9:00:10 AM
More...
|
Telormedix Secures Further Funding With $7.5 Million CHF
1/10/2012 8:20:44 AM
More...
|
Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment
10/31/2011 9:13:42 AM
More...
|
Telormedix Receives EU Funding to Coordinate the Development of Innovative Liposomes for Adjuvant and Vaccine Delivery
9/6/2011 10:44:12 AM
More...
|
Telormedix Appoints Nick Rogerson as New Chairman of the Board
8/2/2011 10:03:18 AM
More...
|
Telormedix and Swiss TPH Institute Sign Malaria and Buruli Ulcer Collaboration
8/3/2010 8:25:50 AM
More...
|
Telormedix TMX-101 Commences Clinical Trial for Bladder Cancer
6/14/2010 6:46:52 AM
More...
|
Telormedix Appoints Phillipe Lutz Chief Financial Officer
5/4/2010 11:41:36 AM
More...
|
|